日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Construction Strategies and Advances in Bone Marrow Microphysiological Systems

骨髓微生理系统的构建策略和进展

Guedj, Maxime; Dufour, Ondine; Charafe-Jauffret, Emmanuelle; Ewald, Jacques; Charrier, Nathalie; Bouchez, Clémentine; Catozzi, Simona; Someil, Laetitia; Cuvier, Caroline; Drouin, Léonor; Teixeira, Luis; Miquel, Catherine; De Bazelaire, Cédric; Levi, Francis; Mullaert, Jimmy; Ballesta, Annabelle; Giacchetti, Sylvie; Qu, Taimei; Tian, Lv; Büyüker, Sultan Mehtap; Khan, Khizar Abdullah; Khalil, Abdul Qadeer Khan; Khan, Imran; Jahan, Shah; Adil, Muhammad; Al-Rohily, Khalid M; Al-Khamees, Abdulmoneem H; Khalil, Atif Ali Khan; Lin, Tian; Zhong, Haodong; Niu, Qianyi; Zhang, Ruiqiu; Zhao, Manman; Zhou, Xiaobing

The role of multi-organ cancer predisposition genes in the risk of inherited and histologically diverse gastric cancer

多器官癌症易感基因在遗传性和组织学异质性胃癌风险中的作用

Joana Guerra ,Ana P Estrada-Florez ,Paul C Lott ,Carla Pinto ,Manuela Pinheiro ,Katherine A Chiu ,Dennis J Montoya ,Hongyong Zhang ,Guadalupe M Polanco-Echeverry ,Pedro Pinto ,Ana Peixoto ,Catarina Santos ,Ana Barbosa ,João Silva ,John Suarez-Olaya ,Fabian Castro-Valencia ,Graciela Molina ,Alejandro H Corvalán ,Adriana Della Valle ,Jose E Castelao ,Nereida Fernandez-Fernandez ,Lucia Cid ,Nora Rios-Sarabia ,Rafael Medrano ,Alejandra Mantilla ,Maria M Echeverry de Polanco ,Ana L Rivera-Herrera ,Julián Riaño-Moreno ,Rafael Parra-Medina ,Luz M González-Castrillón ,Ricardo Dominguez ,Ana R Isidoro ,Fernanda Silva ,Douglas R Morgan ,Alicia M Cock-Rada ,Maria C Sanabria-Salas ,Mabel H Bohorquez ,Javier Torres ,Manuel R Teixeira ,Luis G Carvajal-Carmona

Molecular convergence of luminal androgen receptor and molecular apocrine defines a distinct entity in ER-negative breast tumors

管腔雄激素受体和顶泌分子的分子汇合定义了ER阴性乳腺肿瘤的一个独特实体。

Borgel, Adrien; Camenen, Etienne; Miquel, Catherine; Bertheau, Philippe; Teixeira, Luis; Lehmann-Che, Jacqueline

FDG-PET/CT and Multimodal Machine Learning Model Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

FDG-PET/CT 和多模态机器学习模型预测三阴性乳腺癌新辅助化疗后的病理完全缓解

Groheux, David; Ferrer, Loïc; Vargas, Jennifer; Martineau, Antoine; Borgel, Adrien; Teixeira, Luis; Menu, Philippe; Bertheau, Philippe; Gallinato, Olivier; Colin, Thierry; Lehmann-Che, Jacqueline

Barriers and opportunities related to access to oncology care in Benin: a qualitative study on breast cancer

贝宁肿瘤治疗服务获取方面的障碍与机遇:一项关于乳腺癌的定性研究

Schantz, Clémence; Gnangnon, Freddy Houéhanou Rodrigue; Aboubakar, Moufalilou; Agbodande, Anthelme Kouessi; Puig, Paloma; Denakpo, Justin Lewis; Tonato Bagnan, Angéline; Bottin, Marie; Agbodjavou, Komi Mena; Sacca, Hélène Robin; Teixeira, Luis; Ridde, Valéry

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis

长春瑞滨联合或不联合噻替哌治疗HER2阴性转移性乳腺癌:倾向评分分析

Robert, Aurelia; Gougis, Paul; Dumas, Elise; Loison, Rebecca; De Castelbajac, Victoire; Espie, Marc; Giacchetti, Sylvie; Cuvier, Caroline; Hassani, Lamia; Wassermann, Johanna; Campedel, Luca; Veyri, Marianne; Vozy, Aurore; Spano, Jean Philippe; Teixeira, Luis; Abbar, Baptiste

A Life course approach to investigate breast cancer and migration in the greater Paris area: the SENOVIE study protocol

采用生命历程方法研究大巴黎地区乳腺癌与人口迁移的关系:SENOVIE 研究方案

Coulibaly, Karna; Schantz, Clémence; Teixeira, Luis; Degrées du Loû, Annabel; Des Guetz, Gaëtan; Hocini, Hamid; Zelek, Laurent; Larmarange, Joseph; Gosselin, Anne

Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer

早期乳腺癌患者用药不持续性和不依从性的动态预测

Rinder, Pierre; Marcille, Théo; Sinel-Boucher, Paul; Cals-Maurette, Mallory; Kanoun, Dorra; Levy, Christelle; Teixeira, Luis; Hornus, Pierre; Szeftel, Daniel; Heudel, Pierre-Etienne

Access to oncology care in Mali: a qualitative study on breast cancer

马里肿瘤治疗的可及性:一项关于乳腺癌的定性研究

Schantz, Clémence; Coulibaly, Abdourahmane; Traoré, Alassane; Traoré, Bakary Abou; Faye, Kadiatou; Robin, Julie; Teixeira, Luis; Ridde, Valéry

Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France

曲妥珠单抗德鲁替康用于既往接受过治疗的HER2阳性转移性或不可切除乳腺癌:来自法国临时使用授权项目的真实世界数据

Petit, Thierry; Hajjaji, Nawale; Antoine, Eric-Charles; Benderra, Marc-Antoine; Gozy, Michel; Foa, Cyril; Mouysset, Jean-Loup; Grenier, Julien; Mousseau, Mireille; Mailliez, Audrey; Saghatchian, Mahasti; Lachaier, Emma; Desmoulins, Isabelle; Hennequin, Audrey; Maes, Patricia; Loirat, Delphine; Ricci, Francesco; Diéras, Véronique; Berton, Dominique; Tiong, Florence Lai; Teixeira, Luis; Dohollou, Nadine; Lévy, Christelle; Bachelot, Thomas; Pierga, Jean-Yves